Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.
By S. Bielack, B. Kempf‐Bielack, G. Delling, G. Exner, S. Flege, K. Helmke, R. Kotz, M. Salzer‐Kuntschik, M. Werner, W. Winkelmann and 3 more. Journal of Clinical Oncology, 2002
2,106 citations recorded by the source corpus.
Subfields: Molecular Biology, Pulmonary and Respiratory Medicine, Rheumatology
View Paper: https://www.semanticscholar.org/paper/4c0c86862e9106815b3a18d05897621907107d35
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. (2015, background): “most commonly occurs in the distal femur (43%), proximal tibia (23%), or humerus (10%).(1) The typ-”
- Primary small bowel mesentery de-differentiated liposarcoma causing torsion with no recurrence for 5 years (2018, neutral): “1%) patients developed recurrence after 5 and 10 years after their diagnoses, respectively.([9]) The London experience demonstrated a late”